JY
CLLS

Jeff Yass’s Cellectis CLLS Stock Holding History

Jeff Yass’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52,700
Closed -$150K – 12477
2025
Q3 		$150K Buy
+52,700
New +$137K ﹤0.01% 11282
2022
Q1 		– Sell
-16,100
Closed -$131K – 13064
2021
Q4 		$131K Sell
16,100
-5,200
-24% -$51.1K ﹤0.01% 11942
2021
Q3 		$269K Buy
21,300
+6,800
+47% +$94.2K ﹤0.01% 10830
2021
Q2 		$224K Sell
14,500
-33,000
-69% -$555K ﹤0.01% 11346
2021
Q1 		$960K Sell
47,500
-12,800
-21% -$317K ﹤0.01% 7849
2020
Q4 		$1.63M Buy
60,300
+40,100
+199% +$900K ﹤0.01% 5543
2020
Q3 		$374K Buy
+20,200
New +$358K ﹤0.01% 8273
2020
Q2 		– Sell
-25,800
Closed -$237K – 10192
2020
Q1 		$237K Buy
25,800
+6,400
+33% +$95.5K ﹤0.01% 8395
2019
Q4 		$332K Buy
+19,400
New +$259K ﹤0.01% 7830
2019
Q3 		– Sell
-39,300
Closed -$613K – 10207
2019
Q2 		$613K Sell
39,300
-13,000
-25% -$232K ﹤0.01% 6839
2019
Q1 		$959K Buy
52,300
+11,400
+28% +$202K ﹤0.01% 5116
2018
Q4 		$681K Sell
40,900
-29,700
-42% -$689K ﹤0.01% 5423
2018
Q3 		$1.99M Buy
70,600
+52,900
+299% +$1.52M ﹤0.01% 4004
2018
Q2 		$501K Buy
17,700
+200
+1% +$5.96K ﹤0.01% 6780
2018
Q1 		$551K Sell
17,500
-15,600
-47% -$493K ﹤0.01% 6427
2017
Q4 		$965K Sell
33,100
-20,500
-38% -$558K ﹤0.01% 5310
2017
Q3 		$1.52M Buy
+53,600
New +$1.39M ﹤0.01% 4427

Other funds holding CLLS

BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DRD
Dennis R. Delaney $314M AUM 35.76% 1-Year Est. Return

Jeff Yass's CLLS Position: Q2 2026 in Review

Jeff Yass reduced its Cellectis (CLLS) stake by 23% in Q2 2026, selling an estimated $55.1K and leaving 50,453 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #12200.

Jeff Yass first reported a position in CLLS in Q3 2016 and has held it in 26 quarters since. The position peaked at $1.23M in Q4 2020. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

  • Jeff Yass held 50,453 shares of Cellectis worth $151K as of Q2 2026.
  • Jeff Yass sold 15,489 Cellectis shares in Q2 2026, an estimated $55.1K.
  • Cellectis made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12200 holding.
  • Jeff Yass first reported a position in Cellectis in Q3 2016 and has held it in 26 quarters since.
  • Jeff Yass's Cellectis position peaked at $1.23M in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.